Financial Avengers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Financial Avengers's VRTX Position: Q3 2026 in Review
Financial Avengers reduced its Vertex Pharmaceuticals (VRTX) stake by 17% in Q3 2026, selling an estimated $10.2K and leaving 100 shares worth $52.3K. The position accounts for 0.02% of the portfolio, ranked #60.
Financial Avengers first reported a position in VRTX in Q4 2020 and has held it in 24 quarters since. The position peaked at $181K in Q4 2020. 1,798 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Financial Avengers held 100 shares of Vertex Pharmaceuticals worth $52.3K as of Q3 2026.
- Financial Avengers sold 20 Vertex Pharmaceuticals shares in Q3 2026, an estimated $10.2K.
- Vertex Pharmaceuticals made up 0.02% of Financial Avengers's portfolio in Q3 2026, its #60 holding.
- Financial Avengers first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
- Financial Avengers's Vertex Pharmaceuticals position peaked at $181K in Q4 2020.
- 1,798 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Financial Avengers's 13F filing for Q3 2026, filed 16 Nov 2026.